相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
Stephen A. Harrison et al.
GASTROENTEROLOGY (2021)
Guidelines for the design and conduct of human clinical trials on ingestion-time differences - chronopharmacology and chronotherapy - of hypertension medications
Ramon C. Hermida et al.
CHRONOBIOLOGY INTERNATIONAL (2021)
Circadian clocks in the digestive system
Anneleen Segers et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Sleep and liver disease: a bidirectional relationship
Thomas Marfot et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Dark and bright side of targeting fibroblast growth factor receptor 4 in the liver
Raffaella Maria Gadaleta et al.
JOURNAL OF HEPATOLOGY (2021)
Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management
Thomas Marjot et al.
ENDOCRINE REVIEWS (2020)
Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease
Anand R. Saran et al.
GASTROENTEROLOGY (2020)
Rotating night shift work and non-alcoholic fatty liver disease among steelworkers in China: a cross-sectional survey
Shengkui Zhang et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2020)
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
Jean-Francois Dufour et al.
GUT (2020)
The circadian clock and liver function in health and disease
Atish Mukherji et al.
JOURNAL OF HEPATOLOGY (2019)
Interconnection between circadian clocks and thyroid function
Keisuke Ikegami et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A. Harrison et al.
LANCET (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice
Fan Zhang et al.
CHRONOBIOLOGY INTERNATIONAL (2018)
An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy Volunteers
Amani Al-Khaifi et al.
GASTROENTEROLOGY (2018)
Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents
Leigh Goedeke et al.
HEPATOLOGY (2018)
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
GASTROENTEROLOGY (2018)
Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
Arun Sanyal et al.
LANCET (2018)
Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
Oscar Chavez-Talavera et al.
GASTROENTEROLOGY (2017)
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation
Chai-Wan Kim et al.
CELL METABOLISM (2017)
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
Chiara Degirolamo et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis
Nicole M. Kettner et al.
CANCER CELL (2016)
Chronotherapy: Intuitive, Sound, FoundedaEuro¦But Not Broadly Applied
Julia M. Selfridge et al.
DRUGS (2016)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
A matter of time: study of circadian clocks and their role in inflammation
Stuart J. Carter et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
CCL2 mediates the circadian response to low dose endotoxin
Jose M. Duhart et al.
NEUROPHARMACOLOGY (2016)
Circadian control of oscillations in mitochondrial rate-limiting enzymes and nutrient utilization by PERIOD proteins
Adi Neufeld-Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years
Ulla Ludwig et al.
BMC ENDOCRINE DISORDERS (2015)
Diurnal rhythms of plasma GLP-1 levels in normal and overweight/obese subjects: lack of effect of weight loss
Joaquin Santiago Galindo Munoz et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2015)
Novel Role of Nuclear Receptor Rev-erbα in Hepatic Stellate Cell Activation: Potential Therapeutic Target for Liver Injury
Ting Li et al.
HEPATOLOGY (2014)
Blood-Gene Expression Reveals Reduced Circadian Rhythmicity in Individuals Resistant to Sleep Deprivation
Erna S. Arnardottir et al.
SLEEP (2014)
Sleep-Wake profiles in patients with primary biliary cirrhosis
Sara Montagnese et al.
LIVER INTERNATIONAL (2013)
FGF21 regulates metabolism and circadian behavior by acting on the nervous system
Angie L. Bookout et al.
NATURE MEDICINE (2013)
Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans
Eric Chern-Pin Chua et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β
Han Cho et al.
NATURE (2012)
Circadian Rhythm of Circulating Fibroblast Growth Factor 21 Is Related to Diurnal Changes in Fatty Acids in Humans
Haoyong Yu et al.
CLINICAL CHEMISTRY (2011)
A Circadian Rhythm Orchestrated by Histone Deacetylase 3 Controls Hepatic Lipid Metabolism
Dan Feng et al.
SCIENCE (2011)
Genome-Wide Profiling of the Core Clock Protein BMAL1 Targets Reveals a Strict Relationship with Metabolism
Fumiyuki Hatanaka et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice
Johanna H. M. Stroeve et al.
LABORATORY INVESTIGATION (2010)
Circadian expression of FGF21 is induced by PPARα activation in the mouse liver
Katsutaka Oishi et al.
FEBS LETTERS (2008)
Regulation of bile acid synthesis by the nuclear receptor Rev-erbα
Helene Duez et al.
GASTROENTEROLOGY (2008)
Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease
Silvia Sookoian et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man
T. Lundasen et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Nuclear receptor expression links the circadian clock to metabolism
Xiaoyong Yang et al.
CELL (2006)
Reciprocal regulation of brain and muscle Arnt-like protein 1 and peroxisome proliferator-activated receptor α defines a novel positive feedback loop in the rodent liver circadian clock
Laurence Canaple et al.
MOLECULAR ENDOCRINOLOGY (2006)
Obesity and metabolic syndrome in circadian Clock mutant mice
FW Turek et al.
SCIENCE (2005)
CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor α (PPARα) in mice
K Oishi et al.
BIOCHEMICAL JOURNAL (2005)
Diurnal variation in rat liver thyroid hormone receptor (TR)-α messenger ribonucleic acid (mRNA) is dependent on the biological clock in the suprachiasmatic nucleus, whereas diurnal variation of TRβ1 mRNA is modified by food intake
BZ Doulabi et al.
ENDOCRINOLOGY (2004)
A mouse model of hepatocellular carcinoma - Ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice
K Nicholes et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
分享论文
